Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. by Nandagiri, Vijay Kumar et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
School of Pharmacy Articles School of Pharmacy
1-1-2011
Incorporation of PLGA nanoparticles into porous
chitosan-gelatin scaffolds: influence on the physical
properties and cell behavior.
Vijay Kumar Nandagiri
Royal College of Surgeons in Ireland
Piergiorgio Gentile
Politecnico di Torino, Italy
Valeria Chiono
Politecnico di Torino, Italy
Chiara Tonda-Turo
Politecnico di Torino, Italy
Amos Matsiko
Royal College of Surgeons in Ireland
See next page for additional authors
This Article is brought to you for free and open access by the School of
Pharmacy at e-publications@RCSI. It has been accepted for inclusion in
School of Pharmacy Articles by an authorized administrator of e-
publications@RCSI. For more information, please contact epubs@rcsi.ie.
Citation
Nandagirl VK, Gentile P, Chiono V, Tonda-Turo C, Matsiko A, Ramtoola Z, Montevecchi FM, Ciardelli G. Incorporation of PLGA
nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. Journal of the Mechanical
Behavior of Biomedical Materials. 2011;4(7):1318-27.
Authors
Vijay Kumar Nandagiri, Piergiorgio Gentile, Valeria Chiono, Chiara Tonda-Turo, Amos Matsiko, Zeibun
Ramtoola, Franco Maria Montevecchi, and Gianluca Ciardelli
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/spharmart/2
— Use Licence —
Attribution-Non-Commercial-ShareAlike 1.0
You are free:
• to copy, distribute, display, and perform the work.
• to make derivative works.
Under the following conditions:
• Attribution — You must give the original author credit.
• Non-Commercial — You may not use this work for commercial purposes.
• Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only
under a licence identical to this one.
For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these
conditions can be waived if you get permission from the author.
Your fair use and other rights are in no way affected by the above.
This work is licenced under the Creative Commons Attribution-Non-Commercial-ShareAlike License. To
view a copy of this licence, visit:
URL (human-readable summary):
• http://creativecommons.org/licenses/by-nc-sa/1.0/
URL (legal code):
• http://creativecommons.org/worldwide/uk/translated-license
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/spharmart/2
Accepted Manuscript
Incorporation of PLGA nanoparticles into porous chitosan-gelatin
scaffolds: Influence on the physical properties and cell behaviour
Vijay Kumar Nandagiri, Piergiorgio Gentile, Valeria Chiono, Chiara
Tonda-Turo, Amos Matsiko, Zeibun Ramtoola, Franco Maria
Montevecchi, Gianluca Ciardelli
PII: S1751-6161(11)00102-0
DOI: 10.1016/j.jmbbm.2011.04.019
Reference: JMBBM 336
To appear in: Journal of the Mechanical Behavior of
Biomedical Materials
Received date: 8 February 2011
Revised date: 23 April 2011
Accepted date: 25 April 2011
Please cite this article as: Nandagiri, V.K., Gentile, P., Chiono, V., Tonda-Turo, C., Matsiko,
A., Ramtoola, Z., Montevecchi, F.M., Ciardelli, G., Incorporation of PLGA nanoparticles into
porous chitosan-gelatin scaffolds: Influence on the physical properties and cell behaviour.
Journal of the Mechanical Behavior of Biomedical Materials (2011),
doi:10.1016/j.jmbbm.2011.04.019
This is a PDF file of an unedited manuscript that has been accepted for publication. As a
service to our customers we are providing this early version of the manuscript. The manuscript
will undergo copyediting, typesetting, and review of the resulting proof before it is published in
its final form. Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
G
ra
p
h
ic
al
 A
b
st
ra
ct
Incorporation of PL G A nanoparticles into porous chitosan-gelatin 
scaffolds: influence on the physical properties and cell behaviour 
Vijay Kumar Nandagiria,b,c, Piergiorgio Gentilea, Valeria Chionoa, Chiara Tonda-Turoa, Amos Matsikoc,  
Zeibun Ramtoolab, Franco Maria Montevecchia, Gianluca Ciardellia 
a Department of Mechanics, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy, 
b School of Pharmacy, Royal College of Surgeons in Ireland, 123, St. Stephen Green, Dublin 2, Ireland, 
c Dept. of Anatomy, Royal College of Surgeons in Ireland, 123, St. Stephen Green, Dublin 2, Ireland 
 
Abstract 
Bone regeneration can be accelerated by localized delivery of appropriate growth 
factors/biomolecules. Localized delivery can be achieved by a 2-level system: i) incorporation of 
biomolecules within biodegradable particulate carriers (nanoparticles), and ii) inclusion of such 
particulate carriers (nanoparticles) into suitable porous scaffolds. In this study, freeze dried porous 
chitosan-gelatin scaffolds (CH-G: 1:2 ratio by weight) were embedded with various amounts of 
poly(lactide-co-glycolide) (PLGA) nanoparticles, precisely 16.6%, 33.3% and 66.6% (respect to 
CH-G weight). Scaffolds loaded with PLGA nanoparticles were subjected to physico-mechanical 
and biological characterizations including morphological analysis, swelling and dissolution tests, 
mechanical compression tests and cell viability tests. Results showed that incorporation of PLGA 
nanoparticles into porous crosslinked CH-G scaffolds: i) changed the micro-architecture of the 
scaffolds in terms of mean pore diameter and pore size distribution, and ii) reduced the dissolution 
degree of the scaffolds, and iii) increased the compressive modulus. On the other hand, the water 
uptake behavior of CH-G scaffolds containing PLGA nanoparticles significantly decreased. The 
incorporation of PLGA nanoparticles did not affect the biocompatibility of CH-G scaffolds. 
Keywords: Chitosan; gelatin; genipin; poly(lactide-co-glycolide); porous scaffolds; nanoparticles. 
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1. Introduction 
Bone regeneration is a complex cascade of biological events controlled by numerous bioactive 
molecules that provide signals at local injury sites allowing progenitors and inflammatory cells to 
migrate and trigger healing processes. Conventional tissue engineering strategies utilize 
combination of cells, biodegradable scaffolds and systemic administration of bioactive molecules to 
promote natural processes of tissue regeneration and development (Borenstein et al., 2007). 
However, systemic administration of biomolecules such as growth factors often produces poor 
results, probably due to their short biological half life, lack of tissue specificity, long term 
instability, and potential dose dependent carcinogenicity (Kobsa and Saltzman, 2008; Lee and Shin, 
2007). In addition to this, a well-timed and localized delivery of biomolecules from the scaffold is 
necessary to achieve the desired biomimetic effect (Vasita and Katti, 2006; Zisch et al., 2003). 
A number of strategies for controlled biomolecule delivery from scaffolds has been developed for 
bone tissue engineering. One of the most common methods to achieve controlled and localized 
release of biomolecules is to incorporate them within biomaterials during the phase of scaffold 
fabrication. According to this approach, the properties of the scaffolds, such as pore size and 
crosslinking density, control the biomolecule release rate by diffusion. In addition, the rate of 
scaffold degradation affects the biomolecule release rate over a prolonged time period (Tachibana et 
al., 2006; Kim et al., 2003; Bonadio et al., 1999). Such approaches are often unsatisfactory, as the 
cells may be exposed initially to an excessive concentration of biological molecules which could 
result toxic and, subsequently, to ineffective concentration levels of the biomolecules as a 
consequence of their short half-life and clearance. To overcome these problems, researchers have 
encapsulated biomolecule(s) into polymeric micro/nano-particulate systems, to be subsequently 
incorporated into scaffolds for localized and/or controlled delivery of the biomolecule(s). These 
micro/nano-particulate carrier systems allow controlled release of incorporated biomolecule(s) over 
time and, in addition, increase the biological half life of the biomolecule(s), as they protect them 
from degradation/clearance. Furthermore, the release kinetics of the target biomolecules can be 
modulated by changing the composition of the particulate carrier system, the amount of drug 
encapsulated and the size of the micro/nanoparticles. 
However, when micro/nanoparticles are incorporated into prefabricated porous scaffolds, they often 
tend to aggregate, which may not serve the purpose of controlled/spatial delivery of biomolecules 
(Langer, 1998; Jeong et al., 1997; Ma, 2008). One approach to overcome these limitations is to 
suspend the biomolecules-loaded micro/nanoparticles into biomaterial solutions during the 
crosslinking phase of scaffold fabrication. Few studies in literature have reported the incorporation 
of micro-scale particulate carrier systems within porous scaffolds for localized delivery of 
biomolecules. For example, Perets et al. incorporated bFGF-loaded PLGA microparticles into 
alginate porous scaffolds to enhance vascularization after implantation in rat peritoneum. They 
reported a fourfold increase in number of penetrating capillaries into the bFGF releasing scaffolds 
as compared to their control counterparts. (Perets et al., 2003). Furthermore, Khil et al. have 
designed a type of porous chitosan scaffold, containing chitosan microspheres loaded with TGF-1, 
to enhance chondrogenesis (Khil et al., 2003). They demonstrated that the scaffolds containing the 
loaded chitosan microspheres significantly increased the cell proliferation and production of ECM. 
A similar approach using chitosan-based materials has been reported by Lee et al. (Lee et al., 2004), 
where a three-dimensional collagen/chitosan/glycosaminoglycan scaffolds were seeded with rabbit 
chondrocytes and combined with TGF-1-loaded chitosan microspheres. This set-up allowed for 
evaluating the effect of released TGF-1 on the chondrogenic potential of rabbit chondrocytes in 
such combined systems. 
In all these studies, the authors have mainly emphasized the possibility to achieve a desired 
biological response by localized delivery of biomolecules. However, the influence of particle 
incorporation on the physico-mechanical properties of porous scaffolds has not been properly 
assessed. Recently, Banarjee et al. have reported the effect of poly(lactide-co-glycolide) (PLGA) 
microsphere incorporation on the physical properties as well as the cellular performance of the 
freeze-dried gelatin scaffolds (Banerjee et al., 2009). However, these effects may differ when 
blends of two or more polymers are used to fabricate porous scaffolds and these effects are largely 
dependent on the size of incorporated particles. Nano/ sub-micron particles offer numerous 
advantages over microparticles such as more homogeneous distribution of particles within the 
polymeric solution during the crosslinking step of scaffold fabrication and availability of more 
particles for same equivalent weight of carriers. Moreover, the lengthy diffusion times of 
biomolecules from microparticle(s) carrier matrix can be avoided when nano/sub-micron particles 
are used, which could facilitate the pulsed release of incorporated biomolecules. A further 
advantage with nano/sub-micron particles over microparticles is the prevention of acidic micro-
environment within particle matrix, which is a consequence of hydrolytic degradation of PLGA into 
lactic and glycolic acids. 
In this study, PLGA nanoparticles, containing a model protein, bovine serum albumin (BSA), were 
incorporated into freeze-dried porous scaffolds based on a chitosan\gelatin blend (CH-G) 
crosslinked with genipin (GP). Such a system primarily acts as a local regulator to control doses and 
kinetics of released growth factor, thus increasing their potential retention time at therapeutic 
concentration levels (Kobsa and Saltzman, 2008 and Silvia et al., 2007). 
CH was selected as it is a biodegradable, biocompatible and non toxic naturally derived 
polysaccharide which exhibits haemostatic, antimicrobial and gel-forming properties (Madihally 
and Matthew, 1999). Scaffolds based on CH have been reported to display hydrophilic and cell 
adhesive/differentiating characteristics (VandeVord et al., 2002; Suh and Matthew, 2000). 
Furthermore, the inherent osteoconductive nature of CH enhances its potential for bone tissue 
engineering applications (Lahiji et al., 2000). G is a protein derived from collagen, and it has been 
frequently applied in artificial skin, bone grafts, and scaffolds for tissue engineering (Esposito et al., 
1996; Kawai et al., 2000; Zhao et al., 2002; Ito et al., 2003; Chang et al., 2003). Its wide use in the 
biomedical field is motivated by the presence of Arg-Gly-Asp (RGD)-like sequences that promote 
cell adhesion and migration (Shen et al., 2000). 
When CH and G are blended together, the spatial arrangement of G integrin ligands and CH 
polycationic groups interacting with the anionic cell surface is affected. Thus, blending influences 
cell adhesion, cellular bioactivity and tissue remodelling process and ultimately the quality of the 
regenerated tissue (Huang et al., 2005). The mechanical properties and water stability of CH-G 
blend can be increased by crosslinking with suitable non cytotoxic crosslinking agents. In this work, 
genipin, an aglycone derived from geniposide which is extracted from the fruit of Gardenia 
Jasminoides Ellis, was selected as a crosslinker for CH-G blend (Mi, 2005). PLGA nanoparticles 
were selected as they have a recognized biocompatibility and efficiency in the delivery of growth 
factors, proteins or drugs, in a time dependent manner, both in vitro and in vivo (Muthu, 2005). 
Freeze-drying is one of the most applied methods for fabrication of scaffolds based on CH-G 
blends. Freeze-drying method involves the formation of inter/intra connected ice crystals inside the 
polymer solution(s) during the freezing stage, which then form pores during sublimation leading to 
a porous three dimensional polymeric scaffold (Huang et al., 2005).
The introduction of hydrophobic particulate carriers to obtain a localized delivery of bioactive 
molecules may change the pattern of ice crystal formation and distribution during freezing, which in 
turn may influence the scaffold micro-architecture. 
In this work, the effect of PLGA nanoparticles incorporation on the physical and biological 
properties of freeze-dried GP-crosslinked CH-G scaffold(s) were investigated by analyzing the 
scaffold micro-architecture, porosity, swelling degree, mechanical compressive strength, in vitro 
dissolution, cell attachment and cell viability using clonal human osteoblast cell line (hFOB). 
HFOB cell line is a clonal, conditionally immortalized human foetal cell line capable of osteoblastic 
differentiation and bone formation, that provides a homogeneous, rapidly proliferating model 
system for studying human osteoblast differentiation, physiology, and effects of cytokines on 
osteoblasts (Harris et al., 1995). hFOB is a widely used cell line to reflect human bone biology; 
hence, this cell line was selected to analyse cell viability into CH-G scaffolds incorporating PLGA 
nanoparticles.
2. Materials and methods 
Chitosan (CH), gelatin (G), fraction V bovine serum albumin (BSA), poly vinyl alcohol (MW: 30-
70 kDa, >87-90% hydrolyzed) (PVA) and trehalose were purchased from Sigma Chemicals Co. 
Poly (DL-lactide-co-glycolide) (PLGA) 50:50 (RG 504 H, MW 48,300Da) was obtained from 
Boehringer Ingelheim Pharma GmbH & Co. KG, (Ingelheim, Germany). Genipin (GP) was 
acquired from Challenge Bioproducts Co., Taiwan. For cell culture studies, hFOB (ATCC, MA) 
pre-osteoblastic cells cultured under standard conditions (5% CO2, 37°C) were used. Other reagents 
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red) (Gibco, UK), 10% foetal bovine serum (Sigma-Aldrich), 1% penicillin/streptomycin 10 mg/ml 
(Sigma-Aldrich), trypsinEDTA (Sigma-Aldrich). Alamar blue dye was obtained from Bioscience, 
Ireland. All reagents and solvents used were HPLC grade or analytical grade. 
 
2.1 Preparation of C H-G scaffolds 
CH and G were dissolved in 0.5 M acetic acid (Sigma, Italy) at CH-G 1:2 weight ratio obtaining a 
solution with 3% (w/v) concentration by stirring for 12 h at 40°C. GP crosslinker was added to the 
solution at defined weight percentage (2.5% wt/wt with respect to the CH-G amount). The mixture 
was kept at 50°C under stirring until a gel started to form (approximately 30 minutes). The gel was 
spread on Petri dishes, pre-freezed at 20°C for 12 h and freeze-dried (Scanvac, CoolSafe) for 24 h 
to obtain porous CH-G matrices. After freeze-drying, samples were washed in 70, 90 and 100% w% 
ethanol, for 20 minutes to neutralize the acid content and then repeatedly washed in de-mineralized 
water till pH of washing medium was 7. Washing was also performed to remove un-reacted GP 
residues (Chiono et al., 2008). 
 
2.2 Preparation of BSA loaded PL G A nanoparticles 
PLGA nanoparticles were prepared using a modified double emulsion solvent diffusion method 
(Cohen-Sela et al., 2009). The procedure in brief is as follows. One ml of BSA aqueous phase, 
containing 3% (w/v) trehalose in PBS, was added to 4 ml of 25 mg/ml PLGA solution in ethyl 
acetate and subjected to probe sonication (Branson sonifier 150, Branson Ultrasonics Corporation 
41 Eagle Road, Danbury, CT) for 2 minutes at level 3. The resulting emulsion was transferred into 4 
ml of 2.5% (w/v) PVA (pH 4.5) solution and sonicated for 2 minutes at level 3. After 2 minutes of 
sonication, the mixture was transferred into 25 ml of 1% (w/v) PVA solution and homogenized for 
3 minutes at a speed of 13,500 rpm to form a double emulsion. The organic solvent was evaporated 
by stirring the double emulsion with 25 ml of normal saline at 30°C for 3-4 h (until the solvent was 
evaporated). The nanoparticles were collected by ultra centrifugation at 30,000 rpm for 30 minutes 
(Ultracentrifuge Sorvall RC 5C plus, Maryland, USA), washed three times with purified water and 
freeze-!
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Blank nanoparticles were prepared similarly to the above procedure except for the inclusion of BSA 
in internal aqueous phase. 
 
2.3 Characterization of nanoparticles 
Lyophilized nanoparticles were characterized for particle size, zeta potential, moisture content and 
surface morphology. For measuring particle size and zeta potential, freeze-dried PLGA 
nanoparticles were dispersed in deionized water (1 mg/ml). Approximately 0.1 ml of this 
suspension was diluted in filtered deionized water and transferred in a folded capillary cell avoiding 
the formation of any air bubbles. The mean particle diameter and polydispersity index of particles 
was determined using non-invasive back scatter (NIBS) technology, which allows sample 
measurement in the range of 0.6   6,000 nm by means of photon correlation spectroscopy using a 
Zetasizer (Nano ZS/ZEN 3600, Malvern Instruments, UK). The measurement was carried out using 
a 4 mW He-Ne laser as a light source at a fixed angle of 173°. The following parameters were used 
for the measurements: 1.339 medium refractive index, 0.88 mPas medium viscosity, and 78.54 
dielectric constant, 25°C temperature. Size measurements were carried out by at least 5 runs and in 
triplicate for each sample and results were expressed as the mean size ± standard deviation (SD). 
The morphology of PLGA nanoparticles was analysed by scanning electron microscopy (SEM). 
Freeze-dried PLGA nanoparticles were fixed onto metallic studs with double-sided conductive tape 
(diameter 12 mm, Oxon, Oxford instruments, UK) and coated with gold for 4 minutes under 
nitrogen atmosphere in a Blazers of a sputter coating unit (Agar Sputter coater, Agar Scientific Ltd., 
Essex, UK). A LEO 1450 VP (Leo Electron microscopy Ltd., Cambridge, UK) scanning electron 
microscope (SEM) was used with an acceleration voltage of 1.00 kV and a secondary detector 
(Holzer et al., 2009). 
 
2.4 Preparation of PL G A nanoparticles embedded C H-G scaffolds 
PLGA nanoparticles embedded CH-G scaffolds were obtained by dispersing an aqueous suspension 
of PLGA nanoparticles into CH-G blend solution (3% w/v) at different concentrations: 5 mg, 10 mg 
and 20 mg per ml of CH-G blend solution, respectively (16.6; 33.3; 66.6 w/w PLGA loading with 
respect to CH-G weight). CH-G scaffolds without nanoparticles were prepared for use as a control 
for experimental tests. The ensuing preparative stages, such as crosslinking, lyophilization, and 
neutralization were performed using the same protocols as described in paragraph 2.1. 
 
2.5 Study of scaffold micro-architecture 
Pore size analysis of the scaffolds was carried out using a technique previously described by 
	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
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. 
A total of three scaffolds per group were used in this analysis. Three fixed scaffold sections were 
analyzed: top, middle and bottom surface. In detail, samples were first embedded in JB-4-
glycolmethacrylate (Polysciences Europe, Eppelheim, Germany). The embedded samples were 
sectioned into 10  m thick slices using a microtome (Leica RM 2255, Leica, Germany) and the 
20th slice (representative of the section located at 200  m distance from the surface) was used as 
the middle section. Four serial sections were obtained from each fixed location of each scaffold to 
obtain a total of 12 serial sections. The sections were then mounted on glass slides and stained with 
toluidine blue, then observed under a microscope (Eclipse 90i, Nikon, Japan). Digital images were 
then taken at 10x magnification (image quality 1280 x 1024  16bit, exposure time 3ms) using a 
digital camera (DS Ri1, Nikon, Japan). A total of 36 images of serial sections from each scaffold 
group were obtained. The digital images were evaluated using a specifically developed MatLab 
(The MathWorks Inc, MA, USA) pore topology analyzer software. In order to yield correct results, 
the software was calibrated by setting the pixel to micron ratio using the scale bar on the images. 
The software successively transformed the original images into binary images, removed unwanted 
blotches and generated the pore size. The pore size was defined as the diameter of a circle with a 
cross-sectional area equivalent to that of the best fit ellipse generated by the software (at least 50 
pores/section were considered for each analysis). The mean pore size was calculated from the 
images of each scaffold group statistical significance of data between the groups was evaluated. 
 
2.6 Scaffold morphology 
Scaffold morphology was analyzed using SEM (LEO 1450 VP; Leo Electron microscopy Ltd., 
Cambridge, UK) to study the influence of PLGA nanoparticles into scaffold micro-architecture. 
Three samples were obtained by fracturing each scaffold type and the fractured sections of these 
samples were analysed by SEM. Prior to observation through SEM, scaffolds were sputter coated 
with gold and analyzed at an accelerating voltage of 20 kV. 
 
2.7 Study of the water uptake ability (swelling test) 
The effect of nanoparticle incorporation on water absorption capacity of the scaffolds was 
determined after immersion of cylindrical scaffolds with 8 mm diameter and approximately 4 mm 
thickness in 3 ml of PBS (100 mM, pH 7.4) at 37ºC. Wet weight was determined after 24 h of 
incubation. The percentage of water absorption (Wsw) of the scaffolds was calculated from the 
expression (Banarjee et al., 2009; Thein-Han et al., 2009): 
Wsw = [(W24h W0)/W0] x 100                                                                                                          (1) 
where, W24h represents the wet weight of scaffolds after 24 h of incubation and W0 is the initial 
weight of the scaffolds. The values were expressed as mean ± SD (n=3). 
 
2.8 Mechanical tests 
Uniaxial compressive tests were carried out on cylindrical scaffolds with 8 mm diameter and 4 mm 
height. Samples were pre-hydrated in PBS (100 mM, pH 7.4) for 1 h. All tests were carried out in a 
bath of PBS (100 mM, pH 7.4) at room temperature, using a mechanical testing machine (Zwick-
Roell, Germany) fitted with a 5 N load cell. The tests were carried out on unconfined and 
unlubricated platens. The cross-head speed was set at 0.007 mm·s-1 and the load was applied until 
the specimen was compressed at approximately 10% of its original length. The tests were conducted 
at a strain rate of 10% per minute. Each sample was tested in triplicate and the stress was calculated 
by dividing the applied force with the initial scaffold surface area, whereas strain was calculated 
from the displacement of the scaffolds in relation to the original thickness. A Matlab program was 
run to obtain the stress-strain curves from the acquired data. The compressive modulus (E) was 
calculated as the slope of a linear fit to the stress-strain curves over 2-5% strain (Al-Munajjed and 
	
). Data on the compressive modulus were averaged on three samples for each scaffold 
type. 
 
2.9 Dissolution study 
To study the effect of nanoparticles loading on in vitro dissolution of scaffolds, cylindrical scaffold 
samples of 8 mm diameter and approximately 4 mm thickness were incubated in 3 ml of PBS (pH 
7.4) for 10 days at 37º C. The dissolution degree was calculated in terms of percentage weight loss 
(% WL) using the formula (Banarjee et al., 2009): 
% WL = [(W10  W0) / W0] x 100                                                                                                      (2) 
where, W10 is the dry weight of scaffolds after 10 days of incubation in PBS and W0 is the initial 
weight. The values were expressed as the mean ± SD (n=3). 
2.10. Cell culturing and seeding on scaffolds 
HFOB (ATCC, MA) pre-osteoblastic cells were cultured under standard conditions (5% CO2, 
37°C). Cells were routinely grown to 80% confluency in T175 culture flasks (Sarstedt, Ireland) 
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(without phenol red), 10% foetal bovine serum, 1% penicillin/streptomycin (Sigma-Aldrich). 
Expanded hFOB cells of passage 5 were harvested with trypsinEDTA treatment, centrifuged and 
resuspended in the culture medium. Aliquots of cell suspensions were then evenly seeded by 
instillation onto three samples of each scaffold type for each time interval to be analysed to form 
cell-seeded scaffold constructs with a final seeding density of 4 × 106 cells (2 × 106 cells/ each side 
of scaffold). The constructs were then placed in sterile 6-well plates and 5 ml of the growth medium 
were added into each well after 4 h incubation of cells to allow their attachment. During the culture 
period, the medium was exchanged every two days time interval. Scaffolds were incubated up to 11 
days in the culture medium. 
 
2.11. Cell attachment and V iability of hF O B cells on C H-G scaffold 
At fixed time intervals (1 day, 2 days, 5 days, and 11 days), metabolic viability of hFOB cells on 
the scaffolds was determined by replacing media surrounding the cell seeded constructs with that 
containing 10% v/v Alamar blue dye (Bioscience). The samples (n=3) were incubated in an orbital 
shaker at 37°C, at a shaking rate of 50 rpm for 4 hours. After 4 h, 100  l of media were transferred 
into a 96 well microplate and their UV-visible absorbance at 570 nm and 610 nm was measured 
using a spectrophotometer. Samples were measured in triplicate for each scaffold type. 
After collecting samples for Alamar blue assay, all scaffolds were washed three times by immersing 
in sterile PBS and then incubated in fresh 5 ml growth medium. The percentage of reduced dye as a 
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(Keogh et al., 2010). 
 
2.12. Statistical analysis 
Experiments were run in triplicate for each sample. All data were expressed as mean ± SD for n=3. 
Statistical analysis was determined by using Analyse-it v2.22 software. The statistical differences 
between groups were calculated using Kruskal-Wallis One Way Analysis of Variance on Ranks 
(ANOVA). Statistical significance was declared at p<0.05. 
3. Results 
3.1 Characterization of PL G A nanoparticles 
The PLGA nanoparticles prepared by double emulsion-solvent evaporation method showed a mean 
diameter of 205.0±3.9 nm, with a polydispersity index of 0.23±0.04 (n=3) (Fig. 1a-b). SEM images 
of the nanoparticles showed their regular spherical shape, smooth surface and the absence of 
aggregation. Moreover, no differences were observed in the morphological properties of 
nanoparticles due to the incorporation of BSA protein. (Fig. 1b) 
3.2 Scaffold morphology 
SEM micrographs of PLGA nanoparticles-embedded CH-G scaffolds (Fig. 2a-c) showed that 
PLGA nanoparticles were uniformly distributed on the pore walls independently on the amount of 
PLGA nanoparticles incorporated. However, some aggregates of PLGA nanoparticles were 
observed as the amount of particles increased (Fig. 2c). 
Incorporation of PLGA nanoparticles into freeze-dried CH-G scaffolds did not affect significantly 
the micro-architecture of scaffolds: all scaffold types showed a porous structure with pore 
interconnection (Fig. 3a-d). 
Fig. 4 shows the mean pore size calculated according to the method described at paragraph 2.5. 
Incorporation of PLGA nanoparticles into CH-G scaffolds did not change significantly the mean 
pore size for the scaffolds loaded with 16.6 and 33.3% w/w nanoparticles (110±40  m at 16.6% 
(w/w) loading and 146±63  m at 33.3% (w/w) loading) as compared to the control scaffolds (mean 
pore size of 130±37  m). On the other hand, an increase in the mean pore size (194±70  m) was 
observed when 66.6% (w/w) PLGA nanoparticles were incorporated. 
The mean pore size distribution of the PLGA nanoparticles-embedded CH-G scaffolds is shown in 
Fig. 5. In the case of control CH-G scaffolds, around 60% of pores were in the 100-

range, around 5% of pores had a size lower than 75 higher than 	

were in the 75-100 -200 

 
The incorporation of 16.6% (w/w) PLGA nanoparticles resulted in 15% of pores with a size lower 
than 75 !	 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the 100-150 m size range and the remaining 10% in 150-! 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The incorporation of 33.3% (w/w) PLGA nanoparticles resulted in 52% of pores in the 100-	!
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Finally, the incorporation of 66.6% (w/w) of PLGA nanoparticles resulted in larger pores: around 
45% of pores showed a higher size than !	-! 
	 	! 
In conclusion, pore size distribution of the control scaffolds and CH-G scaffolds incorporating 16.6 
and 33.3% (w/w) PLGA nanoparticles was only slightly different with no change in the overall 
mean pore size (as shown in Fig. 4). On the other hand, in the case of CH-G scaffolds incorporating 
66.6% (w/w) PLGA nanoparticles, pore size distribution was significantly changed as compared to 
the control scaffold and scaffolds containing 16.6 and 33.3% (w/w) nanoparticles, with a prevalence 
of pores having size higher than 150 !mean pore size of scaffolds 
with 66.6% (w/w) PLGA nanoparticles was larger than the values measured for the other samples 
(Fig. 4). 
3.3 Swelling Behaviour 
The water uptake ability of the control scaffolds after 24 h of incubation in PBS was 1245 ±56% 
(Fig. 6). As expected, the incorporation of hydrophobic PLGA nanoparticles reduced the water 
uptake, which was approximately similar for loading values of 16.6% (w/w) (524 ± 35%) and 
33.3% (w/w) (631±190%) (Fig. 6). Scaffolds loaded with 66.6% (w/w) PLGA nanoparticles 
displayed the lowest swelling degree (352 ± 17%). 
In conclusion, the introduction of a relatively small amount of PLGA nanoparticles greatly reduced 
the swelling degree as compared to control CH-G scaffolds: the homogeneous distribution of 
hydrophobic PLGA nanoparticles into the CH-G walls significantly decreased the water uptake. 
3.4 Mechanical properties of scaffolds 
The mechanical compressive strength of the porous CH-G scaffolds was measured by calculating 
the compressive modulus from stressstrain data obtained under a compressive load at a constant 
speed in wet conditions. The compressive modulus of CH-G scaffolds embedding PLGA 
nanoparticles is reported in Fig. 7. Among the tested samples, control scaffolds displayed the 
minimum compressive modulus (6.4±0.8 kPa). For scaffolds containing 33.3% (w/w) PLGA 
nanoparticles, the compressive modulus (54.3±1.9 kPa) was increased approximately by 9 times in 
comparison to that of the control scaffolds. 
The compressive modulus of scaffolds containing 16.6% (w/w) and 66.6% (w/w) PLGA 
nanoparticles was increased approximately by three and six times as compared to that of the control 
scaffolds with the values of 16.9±0.6 kPa and 34.3± 0.7 kPa, respectively. 
In conclusion, the addition of PLGA nanoparticles significantly increased the compressive modulus 
of CH-G scaffolds. However, in case of scaffolds with highest amount of nanoparticles (66.6% 
(w/w)), the compressive modulus was decreased as compared to that of scaffolds containing 33.3% 
(w/w) of nanoparticles. 
3.5 Dissolution tests 
Fig. 8 shows the dissolution degree of CH-G scaffolds after 10 days incubation in PBS as a function 
of the amount of incorporated PLGA nanoparticles. The incorporation of 16.6 and 33.3% (w/w) 
PLGA nanoparticles had no significant effect on the dissolution degree of CH-G scaffolds. On the 
other hand, scaffolds containing 66.6% (w/w) PLGA nanoparticles showed an increased dissolution 
degree. The different behavior of the CH-G scaffolds containing 66.6% (w/w) PLGA nanoparticles 
could be a consequence of their higher porosity and mean pore size as compared to the CH-G 
control scaffolds, increasing the dissolution rate. 
3.7 Cell attachment and V iability of hF O B cells on scaffolds 
Metabolic cell viability study (Fig. 9) showed no significant variation in cell viability for all 
scaffold groups during the first two days of culture time, which suggested that the incorporation of 
PLGA nanoparticles did not affect cell attachment to CH-G porous scaffolds. For all samples, 
metabolic cell viability approximately doubled after 5 days cell culture time and then further 
increased after 11 days culture time. After 5 and 11 days culture time, viability of cells adhered on 
scaffolds incorporating nanoparticles was only slightly decreased as compared to control samples. 
However, these differences in cell viability were not significant. 
4. Discussion 
The choice of the method for biomolecule encapsulation within nanoparticles is usually determined 
by the solubility characteristics of the drug. In this study, the double emulsion-evaporation process 
was adopted since it is known to be superior to other incorporation methods in terms of stability of 
incorporated proteins (Tabata et al., 1993). 
The encapsulation efficiency of BSA (used in this study as a model protein) and the particle size 
were preliminarily optimized by varying the protein:polymer ratio and altering external aqueous 
phase pH and osmolality. Based on these studies, the maximum encapsulation efficiency was 
reached when the amount of polymer was about ten times higher than that of the BSA protein (data 
not shown). The diffusion of BSA from nanoparticle core towards the aqueous external phase was 
prevented by properly selecting the pH of external aqueous phase (near to the i.e.p. of BSA) and by 
increasing its osmolality by adding sodium chloride (data not shown) (Muthu 2009). 
During freezing of CH-G solutions containing PLGA nanoparticles (0.00-66.6% (w/w)), the 
interaction of water molecules with the hydrophobic surface of PLGA nanoparticles affected the 
final pore size distribution of scaffolds. Water molecules in contact with the hydrophobic surfaces 
of PLGA nanoparticles could not form inter-molecular hydrogen bonds with the hydrophobic 
surface. Instead, they formed highly connected self assembled structures by intra-molecular 
hydrogen bonding with other water molecules. However, an amount of PLGA nanoparticles of 
16.6% (w/w) and 33.3% (w/w) only slightly influenced scaffold morphology. On the other hand, 
CH-G scaffolds loaded with 66.6% (w/w) PLGA nanoparticles showed an increased porosity degree 
and pore size (75% of pores were larger than 150  m). This behavior was a consequence of the 
distribution of nanoparticles within the scaffolds: the PLGA nanoparticles were homogenously 
distributed into the scaffold pore walls when they were present at an amount of 16.6-33.3% (w/w) 
(Fig. 2a-b). On the other hand, PLGA nanoparticles formed some aggregates when loaded at 66.6% 
(w/w) concentration (Fig. 2c). A similar result was found by Banerjee et al. for PLGA particles 
embedded within porous gelatin scaffolds (Banerjee et al., 2009). In addition, the viscosity of the 
CH-G solution was expected to increase due to PLGA nanoparticle addition in a dose dependant 
manner (Gong et al., 2006), retarding the water molecule diffusion during freezing and leading to an 
irregular porous structure as shown in Fig. 5. 
Both the hydration degree and the degradation behavior are the most important properties of 
materials aimed at biomedical or environmental applications, as their lifetime is mainly governed by 
these two intimately correlated processes. For degradable polymers, degradation occurs as a result 
of natural biological processes or other factors such as hydrolysis. Additionally, the drug release 
rate is mostly influenced by two factors: the diffusion of the drug out of the scaffold and the water 
uptake of the polymeric matrix. Therefore, the preparation of systems for controlled drug release 
applications requires the knowledge of water uptake and degradation rate. 
In the case of in vitro dissolution tests, scaffolds displayed a similar dissolution degree for PLGA 
nanoparticle loading in the 0-33.3% (w/w) range. A significant increase of the dissolution degree 
was found for the CH-G scaffold loaded with 66.6% (w/w) PLGA nanoparticles: this behavior was 
probably a consequence of its superior porosity degree and pore size. Furthermore, the time 
dependant degradation of PLGA particles themselves by means of hydrolysis could have augmented 
the weight loss percentage in scaffolds with the highest amount of PLGA nanoparticles. 
The swelling degree of CH-G scaffolds was strongly decreased by the addition of a relatively low 
amount of PLGA nanoparticles (Fig. 6). Scaffolds with 16.6% (w/w) and 33.3% (w/w) PLGA 
nanoparticles showed a similar swelling degree; on the other hand, the loading of 66.6% (w/w) 
PLGA nanoparticles further decreased the swelling degree, probably as a consequence of increased 
porosity degree and mean pore size. 
The incorporation of PLGA nanoparticles within CH-G scaffolds increased the compressive 
modulus of scaffolds (Fig. 7) in comparison to the control CH-G scaffolds. The compressive 
modulus increased with increasing PLGA nanoparticles amount from 0% w/w to 33.3% w/w. On 
the other hand, the compressive modulus of scaffolds containing 66.6% (w/w) PLGA nanoparticles 
decreased as compared to that of scaffolds containing 33.3% w/w PLGA nanoparticles, probably 
because of their increased porosity degree and mean pore size. In general, the resistance area of a 
material sample decreases with increasing pore size and porosity degree, reducing its mechanical 
resistance. Cell viability studies were performed to examine the effect of the incorporation of 
hydrophobic nanoparticles within the hydrophilic CH-G scaffolds on cell attachment and cell 
viability. Results after 1 d and 2 d incubation time showed that all scaffolds induced a similar 
degree of cell attachment (Fig. 9) which indicates that incorporation of PLGA nanoparticles into 
CH-G scaffolds did not affect cell attachment behaviour. However, for scaffolds loaded with 
different amounts of PLGA nanoparticles, a slight, not significant decrease in cell viability was 
detected after 5 d and 11 d culture time. This behavior could be explained by the degradation 
phenomena involving PLGA nanoparticles and making the local environment slightly acidic. 
5. Conclusion 
Three dimensional porous GP-crosslinked CH-G scaffolds incorporated with PLGA nanoparticles 
were produced as suitable systems for the localized delivery of bioactive agents in scaffolds for 
bone regeneration, such as growth factors, drugs, etc. This study disclosed the changes in physical 
properties of porous CH-G scaffolds as a consequence of incorporation of PLGA nanoparticles in 
three different percentages. The study revealed that loading of hydrophobic PLGA nanoparticles in 
relatively hydrophilic GP-crosslinked CH-G scaffold altered the scaffold microenvironment and 
modulated water uptake, compressive modulus, and dissolution properties. On the other hand, 
incorporation of PLGA nanoparticles within CH-G scaffolds did not affect significantly cell 
attachment and viability after 1-11 days cell culture time. This study was aimed at the design of a an 
optimized matrix for controlled release of biomolecules for bone tissue engineering applications. 
Based on the results of this study, the incorporation of 33.3% w/w of PLGA nanoparticles within 
CH-G scaffolds yielded scaffolds with enhanced mechanical properties, retaining other desirable 
physical and cell attachment properties. Further studies describing the encapsulation and release of 
therapeutic proteins, such as Bone Morphogenetic Protein (BMP2)/ parathyroid hormone (PTH) 
from the optimized scaffolds formulations are in progress. 
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F igure 
Fig 1. SEM images of (a) unloaded PLGA and (b) BSA-loaded PLGA nanoparticles (bar: 1  m). 
 
Fig 2. SEM images of fractured sections of CH-G scaffolds showing distribution of PLGA 
nanoparticles on pore walls of CH-G scaffolds doped with: (a) 16.6% w/w, (b) 33.3% w/w and (c) 
66.6% w/w of PLGA nanoparticles (bar: 2  m). 
 
Fig 3. SEM images of fractured sections of CH-G scaffolds embedding different amounts of PLGA 
nanoparticles: (a) 0% w/w (control), (b) 16.6% w/w, (c) 33.3% w/w, and (d) 66.6% w/w of PLGA 
nanoparticles (bar 200  m). 
 
Fig 4: Mean pore diameter of CH-G scaffolds as a function of PLGA nanoparticle amount. For each 
scaffold type, 50 pores were analyzed to get the mean pore size. Values are mean ± S.D. (n=3). 
 
Fig 5. Effect of the amount of nanoparticles on pore size distribution. At least, 50 pores were 
analyzed to get the mean pore size distribution. Values are mean ± S.D. (n=3). 
 
Fig 6: Effect of PLGA nanoparticles incorporation on water uptake of scaffolds after 24h of 
incubation in PBS. Columns are the mean values; bars represent the standard deviation (n=3). Data 
show statistical difference respect to the control * (p<0.05). 
 
Fig 7: Compressive modulus of CH-G scaffolds as a function of nanoparticle amount. Columns are 
the mean values; bars represent standard deviation (n=3). Data show statistical difference respect to 
the control * (p<0.05) and ** (p<0.0001). 
  
Fig 8: Effect of amount of PLGA nanoparticles incorporation on dissolution properties of scaffolds 
after 10 days of incubation in PBS. Columns are the mean values; bars represent standard deviation 
(n=3). Data show statistical difference respect to the control * (p<0.05). 
 
Fig 9: Effect of PLGA nanoparticle incorporation on metabolic viability (Alamar Blue assay) of 
hFOB cells seeded onto the scaffolds for 1, 2, 5 and 11 days. Columns are the average data, bars are 
the standard deviation.  
 
